Loading organizations...
Efung Capital operates as a specialized venture capital firm, focusing investments in biopharmaceuticals and high-end medical devices. The firm employs a team with deep medical and scientific expertise, supporting companies from early development through clinical stages. Its strategic approach emphasizes rigorous evaluation, fostering long-term value across its life science portfolio.
Jinqiao Zhu founded Efung Capital, officially establishing it in 2007. This built upon his prior significant healthcare investments, like Mindray Medical in 2001, demonstrating foundational sector understanding. The core insight driving its formation was the substantial long-term value in innovative healthcare technologies, leading to its transformation into a dedicated life science venture capital firm by 2012.
Efung Capital invests globally in companies developing advanced biopharmaceuticals and medical technologies. The firm accelerates development and commercialization of these innovations, enhancing the global healthcare landscape. Its long-term vision centers on nurturing groundbreaking companies addressing critical medical needs and improving patient outcomes.
Key people at Efung Capital.
Efung Capital was founded in 2007 by Jinqiao Zhu (Founder).
Efung Capital was founded in 2007 by Jinqiao Zhu (Founder).
Efung Capital has 15 tracked investments across 14 companies. The latest tracked deal is $14.3M Series B in Yuewei Medical in January 2026.
Key people at Efung Capital.